Alliston T N, Maiyar A C, Buse P, Firestone G L, Richards J S
Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030, USA.
Mol Endocrinol. 1997 Dec;11(13):1934-49. doi: 10.1210/mend.11.13.0033.
Recently, a family of novel, serine/threonine protein kinases has been identified. One of these transcriptionally inducible, immediate-early genes encodes serum/glucocorticoid inducible-protein kinase, sgk. By in situ hybridization, we show that sgk expression in the rat ovary is selectively localized to granulosa cells. In culture, FSH or forskolin, activators of the protein kinase A (PKA) pathway, rapidly (2 h) and transiently increased sgk mRNA levels in undifferentiated granulosa cells. Sgk mRNA exhibited a biphasic expression pattern, with maximal levels observed at 48 h of FSH/forskolin as granulosa cells differentiate to the preovulatory phenotype. Deletion analyses using sgk promoter-reporter constructs (-4.0 kb to -35 bp) identified a region between -63 and -43 bp that mediated FSH and forskolin-responsive transcription in undifferentiated and differentiated granulosa cells. This G/C-rich region 1) conferred both basal and inducible transcription to the minimal -35 sgk promoter chloramphenicol acetyltransferase reporter construct, 2) specifically bound Sp1 and Sp3 present in granulosa cell extracts, and 3) bound recombinant Sp1. Mutation of 2 bp in this region not only prevented Sp1 and Sp3 binding, but also abolished the PKA-mediated transactivation observed when using the wild type construct. Sp1 and Sp3 DNA-binding activity and protein levels did not change significantly during sgk induction. Collectively, these data indicate that Sp1/Sp3 transactivation of the sgk promoter likely involves regulated, phosphorylation-dependent interaction with other factors. Thus the novel, biphasic induction of sgk that correlates with granulosa cell progression from proliferation to differentiation appears to involve sequential, coordinated actions of FSH, PKA, and transcription factors, including Sp1 and Sp3.
最近,已鉴定出一类新的丝氨酸/苏氨酸蛋白激酶。这些转录诱导型即早基因之一编码血清/糖皮质激素诱导蛋白激酶(sgk)。通过原位杂交,我们发现大鼠卵巢中sgk的表达选择性地定位于颗粒细胞。在培养中,蛋白激酶A(PKA)途径的激活剂促卵泡激素(FSH)或福斯高林可迅速(2小时)并短暂增加未分化颗粒细胞中sgk的mRNA水平。sgk mRNA呈现双相表达模式,在FSH/福斯高林作用48小时、颗粒细胞分化为排卵前表型时观察到最高水平。使用sgk启动子-报告基因构建体(-4.0 kb至-35 bp)进行的缺失分析确定了-63至-43 bp之间的一个区域,该区域介导未分化和分化颗粒细胞中FSH和福斯高林应答性转录。这个富含G/C的区域:1)赋予最小的-35 sgk启动子氯霉素乙酰转移酶报告基因构建体基础转录和诱导转录能力;2)特异性结合颗粒细胞提取物中存在的Sp1和Sp3;3)结合重组Sp1。该区域中2个碱基对的突变不仅阻止了Sp1和Sp3的结合,还消除了使用野生型构建体时观察到的PKA介导的反式激活。在sgk诱导过程中,Sp1和Sp3的DNA结合活性及蛋白水平没有显著变化。总体而言,这些数据表明sgk启动子的Sp1/Sp3反式激活可能涉及与其他因子的受调控的、磷酸化依赖性相互作用。因此,与颗粒细胞从增殖到分化过程相关的sgk的新型双相诱导似乎涉及FSH、PKA和转录因子(包括Sp1和Sp3)的顺序、协同作用。